|
|
Preparation and in vitro Characteristics of Collagen/ Fibrin/BSA Microspheres Complex Tissue Engineering Scaffolds |
1 School of Life Science and Technology, Xinxiang Medical University, Xinxiang 453003, China
2 School of Pharmacy, Xinxiang Medical University, Xinxiang 453003, China
3 Institute of Biomedical Engineering , Chinese Academy of Medical Sciences & Peking Union Medical College , Tianjin 300192, China |
|
|
Abstract In order to overcome the problem of nutrition insufficiency and inhomogeneous distribution in tissue engineering scaffolds, a scaffold (SCFM) composed of collagen/fibrin/BSA microspheres was prepared and the features were characterized, especially the release behaviors of BSA. Porous collagen scaffolds for tissue engineering were fabricated by freezedrying and crosslinking. BSA loaded microspheres mixed with fibrin into collagen scaffolds for SCFM. The physiochemical properties of the scaffolds, such as surface morphology, porosity, pore sizes,mechanical function, and BSA contents in the scaffold were measured. SEM results showed that collagen scaffolds exhibited a highly porous and interconnected structure, the pore size of the material was (130±45) μm. Results of in vitro release tests revealed the BSA released from SCFM was 72.36%±3.48% of the original amount of BSA encapsulated after 144 h. The cumulative release of BSA from collagen/fibrin/BSA scaffolds (SCFB) within 48 h was 75.20%±2.74 %. There were no significant changes in the further prolonged period after 48 h. The SCFM achieved a relatively constant release and prolonged BSA release properties as compared to the SCFB. It was found that BSA concentration inside of SCFMwas higher than the external release medium before 96 h. The conformations of the BSA from the SCFM did not have significant changes. The SCFMobtained sustaining release ability and can maintain a homogeneous concentration of the BSA inside the scaffold for a long time. Therefore it provides a kind of promising scaffolds for tissue engineering.
|
|
|
|
|
[1]史佳巍,李学敏,刘玲蓉,等. D-核糖交联胶原膜的性质研究 [J]. 功能材料,2009,6(40):1013-1016.
[2]Chen Hongli, Chen Han, Liu Lingrong, et al. The study of improved controlled release of vincristine sulfate from collagenchitosan complex film [J]. Artif Cells Blood Substitues Immobilization Biotechnol, 2008, 36(4): 372-385.
[3]Bjork JW, Sandra JL, Tranquillo RT, Rutheniumcatalyzed photo crosslinking of brinbased engineered tissue [J]. Biomaterials, 2011,32(10):2479-2488.
[4]Spicer PP, Mikos AG, Fibrin glue as a drug delivery system [J]. J Controlled Release, 2010,148(1) : 49-55.
[5]Stephanie MW, Allison R, Shelly ES, The Effect of controlled growth factor delivery on embryonic stem cell differentiation inside of fibrin scaffolds [J]. Stem Cell Res, 2008,1(3): 205-218.
[6]Mónica SVF, Willi JD, Norina L, Cord bloodhematopoietic stem cell expansion in 3D brin scaffolds with stromal support [J]. Biomaterials, 2012,33(29):6987-6997.
[7]Victor KL, Christina RF, Allan MK, et al. Microstructural and mechanical differences between digested collagenfibrin cogels and pure collagen and brin gels [J]. Acta Biomater, 2012,8(11):4031-4042.
[8]Le YB, Polio S, Lee W, et al. Bioprinting of collagen and VEGFreleasing brin gel scaffolds for neural stem cell culture [J]. Exp Neurol, 2010, 223(2):645652.
[9]陈红丽,吕洁丽,晏杰,等. 壳聚糖修饰的PLGA纳米粒作为蛋白多肽类药物载体的研究 [J]. 功能材料, 2011,2(42):202-205.
[10]谷海刚,金旭, 龙大宏,等. BSAPLG微球的制备条件优化及不同添加剂对包封率的影响 [J]. 中国生物医学工程学报,2007,26(6):931-935.
[11]Park KH, Kim H, Moon S, et al. Bone morphogenic protein2 (BMP2) loaded nanoparticles mixed with human esenchymal stem cell in fibrin hydrogel for bone tissue engineering [J]. J Biosci Bioeng, 2009,108 (6):530537.
[12]Liang MS, Andreadis ST, Engineering brinbinding TGF-β1 for sustained signaling and contractile function of MSC based vascular constructs [J]. Biomaterials, 2011,32(33) :8684-8693.
[13]Rieux A, Shikanov A, Shea LD. Fibrin hydrogels for nonviral vector delivery in vitro [J]. J Controlled Release, 2009,136(2) :148-154.
[14]Yang Yanfang, Tang Gongwen, Zhang Hong, et al. Controlled release of BSA by microsphereincorporated PLGA scaffolds under cyclic loading [J]. Mater Sci Eng C, 2011, 31(2):350-356.
[15]Ozkana S, Dilhan MK, Yu Xiaojun , et al. Multifunctional proteinencapsulated polycaprolactone scaffolds: Fabrication and in vitro assessment for tissue engineering [J]. Biomaterials, 2009,30(26): 4336-4347.
[16]陈红丽,陈汉,李学敏,等. 硫酸长春新碱PLGA微球的制备及其基本性质 [J]. 中国医学科学院学报,2007,29(3):342-346.
[17]Ho ML, Fu YC, Wang GJ, et al. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite [J]. J Controlled Release, 2008, 128(2): 142-148.
[18]Wang Qisui, Liu Pengfei, Zhou Xiaolan, et al. Thermodynamic and conformational investigation of the influence of CdTe QDs size on the toxic interaction with BSA [J]. J Photochem Photobiol A, 2012, 230(1):23-30.
[19]宋克东,刘天庆,郭文华,等. 包埋 PLGA 微球的可控释壳聚糖支架材料的研究 [J]. 高校化学工程学报,2010,24(6):985-992. |
|
|
|